Javascript must be enabled to continue!
Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker
View through CrossRef
Objective: To determine the association of serum osteoprotegerin (OPG) with the severity of chronic liver disease in female patients.
Methods: This case-control study was conducted in Madina Teaching Hospital from 2019-2020.An institutional review board of University Medical and Dental College, The University of Faisalabad gave the approval to conduct the study. Only female patients of age group 40 to 60 years having CLD were included in this study. Total 80 participants were enrolled after fulfilling the inclusion and exclusion criteria. Serum OPG levels were measured by enzyme linked immunosorbant assay (ELISA) supplied by ELAB Sciences, USA. The severity of disease was assessed by Child-Pugh classification.
Results: OPG levels were significantly different between the three Child-Pugh classes. OPG levels were significantly high in class C indicating increased level of this cytokine in CLD as compared to class A (p = <0.05). There was a positive association of OPG with splenomegaly (OR = 2.10, p = <0.001), hepatomegaly (OR = 4.41, (p = < 0.05), skin pigmentation (OR = 2.06, p = <0.05), malena (OR = 1.87, p = <0.05) and prolonged bleeding (OR = 1.86, p = <0.05).
Conclusion: The levels of serum Osteoprotegerin is increased in severe form of chronic liver disease (Class C) of Child-Pughs classification as compared to mild (Class A) and moderate (Class B) forms of Child-Pughs classification.
doi: https://doi.org/10.12669/pjms.36.6.2678
How to cite this:Tariq S, Tariq S, Hussain S, Baig M. Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker. Pak J Med Sci. 2020;36(6):1325-1329. doi: https://doi.org/10.12669/pjms.36.6.2678
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Pakistan Journal of Medical Sciences
Title: Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker
Description:
Objective: To determine the association of serum osteoprotegerin (OPG) with the severity of chronic liver disease in female patients.
Methods: This case-control study was conducted in Madina Teaching Hospital from 2019-2020.
An institutional review board of University Medical and Dental College, The University of Faisalabad gave the approval to conduct the study.
Only female patients of age group 40 to 60 years having CLD were included in this study.
Total 80 participants were enrolled after fulfilling the inclusion and exclusion criteria.
Serum OPG levels were measured by enzyme linked immunosorbant assay (ELISA) supplied by ELAB Sciences, USA.
The severity of disease was assessed by Child-Pugh classification.
Results: OPG levels were significantly different between the three Child-Pugh classes.
OPG levels were significantly high in class C indicating increased level of this cytokine in CLD as compared to class A (p = <0.
05).
There was a positive association of OPG with splenomegaly (OR = 2.
10, p = <0.
001), hepatomegaly (OR = 4.
41, (p = < 0.
05), skin pigmentation (OR = 2.
06, p = <0.
05), malena (OR = 1.
87, p = <0.
05) and prolonged bleeding (OR = 1.
86, p = <0.
05).
Conclusion: The levels of serum Osteoprotegerin is increased in severe form of chronic liver disease (Class C) of Child-Pughs classification as compared to mild (Class A) and moderate (Class B) forms of Child-Pughs classification.
doi: https://doi.
org/10.
12669/pjms.
36.
6.
2678
How to cite this:Tariq S, Tariq S, Hussain S, Baig M.
Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker.
Pak J Med Sci.
2020;36(6):1325-1329.
doi: https://doi.
org/10.
12669/pjms.
36.
6.
2678
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.
org/licenses/by/3.
0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
EVALUATION AND COMPARISON OF LIVER MARKERS IN ACUTE LIVER FAILURE VS CHRONIC LIVER FAILURE IN DISTRICT FAISALABAD: A CROSS-SECTIONAL STUDY
EVALUATION AND COMPARISON OF LIVER MARKERS IN ACUTE LIVER FAILURE VS CHRONIC LIVER FAILURE IN DISTRICT FAISALABAD: A CROSS-SECTIONAL STUDY
Background: Liver failure is a life-threatening clinical condition resulting from the inability of the liver to maintain its metabolic, synthetic, and detoxification functions. Acu...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma
Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma
Abstract
Background
About 20% of patients infected with SARS-CoV-2 develop COVID-19—the disease that has dominated health care in the last two years...
Inflammation, etiologies and Model for End‐stage Liver Disease score: What makes liver disease patients susceptible to developing colorectal neoplasia?
Inflammation, etiologies and Model for End‐stage Liver Disease score: What makes liver disease patients susceptible to developing colorectal neoplasia?
AimResearch has identified patients with chronic liver disease as a risk group for colorectal neoplasia. In this study, we aimed to identify liver disease subgroups at enhanced ris...
Association Between Serum Uric Acid Level and the Severity of Parkinsons Disease: A cross sectional study
Association Between Serum Uric Acid Level and the Severity of Parkinsons Disease: A cross sectional study
Background: Parkinson’s disease is a chronic, progressive, neurodegenerative disease. Various factors have been attributed to the development and progression of the diseaseover the...

